REFERENCES
- Tamburini M. Health-related quality of life measures in cancer. Ann Oncol 2001; 12(Suppl 3): 7–10.
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 364–76.
- Cella DF, Tulsky DS, Gray G, et al. The Functional Assess-ment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 1993; 11(3): 570–9.
- Schipper H, Clinch J, McMurray A, Levitt M. Measuring quality of life of cancer patients: the functional living index cancer: developement and validation. J Clin Oncol 1984; 2: 472–83.
- De Haes JCJM, van Knippenberg FCE, Neijt JP. Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990; 62: 1034–8.
- Klee M, Groenvold M, Machin D. Quality of life of Danish women: population-based norms for the EORTC QLQ-C30. Qual Life Res 1996; 7: 27–34.
- Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345–1.
- Hjermstad MJ, Fayers P, Bjordal K, Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer quality-of-life questionnaire: the QLQ-C30(+ 3). J Clin Oncol 1998; 16: 1188–96.
- Michelson H, Bolund C, Nilsson B, Brandberg Y Health-related quality of life measured by the EORTC QLQ-C30 reference values from a large sample of the Swedish population. Acta Oncol 2000; 39: 477–84.
- Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer 2001; 37: 1331–4.
- Gandek B, Ware JE, Aaronson NK, et al. Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA project. J Clin Epidemiol 1998; 51: 1149–58.
- Cella D, Zagara MJ, Vandoros Ch, et al. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general popula-tion. J Clin Oncol 2003; 21: 366–73.
- Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Center on Outcomes, Research and Education (CORE). Evanston: Northwestern Healthcare and Northwestern University; 1997.
- Greil R, Holzner B, Kemmler G, Kopp M, et al. Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. Eur J Cancer 1999; 35: 698–706.
- Holzner B, Kemmler G, Moschen R, et al. Quality of life in breast cancer patients-not enough attention to long-term survivors. Psychomatics 2001; 42: 117–23.
- Kopp M, Schweigkofler H, Holzner B, et al. Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessment. Ann Hematol 1998; 77: 27–32.
- Dapueto JJ, Francolino C, Gotta I, et al. Evaluation of the Functional Assessment of Cancer Therapy-General Question-naire (FACT-G) in a South American Spanish speaking population. Psychooncology 2001; 10: 88–92.
- Grausgruber A. PatientInnenbefragung als Instrument zur Qualitatssicherung. Soziale Sicherheit 2001; 3: 261–8.
- Kiebert G, Wait S, Bernhard J, et al. Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups. Qual Life Res 2000; 9: 1073–80.
- Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 1998; 51: 1055–68.
- Unruh AM, Ritchie J, Merskey H. Does gender affect appraisal of pain and pain coping strategies? Clin J Pain 1999; 15: 31–40.
- Kemmler G, Holzner B, Dfinser M, et al. Comparison of two quality of life instruments for cancer patients: the Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncology 1999; 17: 2932–40.
- Sullivan M, Karlsson J, Ware JE Jr. The Swedish SF-36 health survey-I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med 1995; 41: 1349–58.
- Brorsson B, Ifver J, Hays RD. The Swedish Health-Related Quality of Life Survey (SWED-QUAL). Qual Life Res 1993; 2: 33–45.
- Neitzert CS, Ritvo P, Dancey J, et al. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 1998; 22: 409–22.
- Dow KH, Ferell BR, Leigh S, et al. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 1996; 39: 261–73.
- Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999; 48: 1507–15.
- Sprangers MA, Van Dam FS, Broersen J, et al. Revealing response shift in longitudinal research on fatigue-the use of the then-test approach. Acta Oncol 1999; 38: 709–18.
- Loge JH, Abrahamsen AF, Ekeberg O, Kaasa S. Reduced health-related quality of life among Hodgkin's disease survi-vors: a comparative study with general population norms. Ann Oncol 1999; 10: 71–7.
- Ganz PA, Moinpour CM, Pauler DK, et al. Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 2003; 15(21): 3512–9.